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Most of the known approved drugs comprise functionalized heterocyclic compounds as
subunits. Among them, non-ﬂuorescent quinazolines with four different substitution patterns
are found in a variety of clinically used pharmaceuticals, while 4,5,7,8-substituted quinazo-
lines and those displaying their own speciﬁc ﬂuorescence, favourable for cellular uptake
visualization, have not been described so far. Here we report the development of a one-pot
synthetic strategy to access these 4,5,7,8-substituted quinazolines, which are ﬂuorescent and
feature strong antiviral properties (EC50 down to 0.6±0.1 mM) against human cytomegalo-
virus (HCMV). Merging multistep domino processes in one-pot under fully metal-free con-
ditions leads to sustainable, maximum efﬁcient and high-yielding organic synthesis.
Furthermore, generation of artesunic acid–quinazoline hybrids and their application against
HCMV (EC50 down to 0.1±0.0mM) is demonstrated. Fluorescence of new antiviral hybrids
and quinazolines has potential applications in molecular imaging in drug development and
mechanistic studies, avoiding requirement of linkage to external ﬂuorescent markers.
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Q
uinazoline heterocycles are ubiquitous in pharmaceutical
compounds and drugs. They are important subunits of a
broad variety of natural products as well as synthetic
pharmaceuticals possessing anti-inﬂammatory1, antiviral2,
antimalarial3 and anticancer4 activities. The known quinazoline-
based drugs, which are not demonstrating ﬂuorescence properties,
can be divided into four groups A–D (2,4,6,7-; 4,6,7-; 2,4,5,6- and
2,4,6,7,8-substituted quinazolines), representing four types of
existing substitution patterns (Fig. 1a).
The synthesis of known quinazoline heterocycles by conven-
tional ways is a hard work that implies many synthetic steps and
expensive starting materials, and involves time-consuming
and waste-producing isolation and puriﬁcation of product
intermediates4–8. The number of synthetic methods to afford
quinazolines is, furthermore, restricted to the availability of the
appropriate starting compounds. For this reason, development of
new efﬁcient and straightforward synthetic methods towards
quinazoline heterocyclic compounds of value to medicinal
chemistry, starting from simple precursors, is of high current
demand. To our knowledge, the class of 4,5,7,8-substituted
quinazolines (E-type, Fig. 1b) have not been prepared to date
because of the lack of a synthetic route towards these compounds.
Furthermore, no examples of ﬂuorescent quinazolines have been
reported so far. External ﬂuorescent labels are usually employed
to study the functions of quinazoline-based pharmacophores
within cells. However, ﬂuorescent markers can inﬂuence or
change the properties of studied lead compounds and drugs.
Therefore, the drug candidate should ideally display its own
ﬂuorescence to allow its cellular uptake visualization and without
incorporation of external ﬂuorescent labels. The motivation and
desire to address these gaps prompted the research work we
report here.
Recently, combined processes, where several fundamentally
different catalytic reactions are joined in a one-pot protocol,
were introduced9. Among known examples are combinations
of (i) organocatalysis and transition–metal catalysis10,
(ii) organocatalysis and silver or gold catalysis11–13 or
(iii) organocatalysis and (photo)redox catalysis14,15. Even
more efﬁcient and economical methods towards heterocyclic
compounds are domino processes16–22.
In terms of efﬁciency and sustainability, generation of bioactive
heterocycles through multicomponent multistep reactions avoiding
intermediate isolation and puriﬁcation steps, is unbeatable. While
examples of organocatalysed linear domino reactions17,18,20 and of
a single branched domino process21 are known, surprisingly,
combining them in one-pot is unprecedented, although such a
multistep one-pot process would further reduce costs and waste
production in the synthesis of versatile heterocycles.
Herein, we describe development of a combined process, which
joins a new ﬁve-step branched domino reaction with two-step
linear and subsequent three-step linear domino reactions. This
new metal-free 10-step sequence, with only a single work up
procedure and starting from simple and readily available
compounds, results in new functionalized quinazolines of type
E (Fig. 1b), which exceed the antiviral potency of the clinical
reference drug ganciclovir23. Furthermore, selected ﬂuorescent
quinazolines were applied for synthesis of ﬁrst artesunic acid–
quinazoline hybrids, which are, remarkably, also ﬂuorescent and
display superior potency against HCMV (EC50 down to
0.1±0.0 mM) compared to that of their parent quinazolines
(EC50 down to 4.6±0.9 mM) and artesunic acid (EC50
3.8±0.4 mM), as well as ganciclovir (EC50 2.6±0.5 mM). For all
quinazoline compounds, cytotoxicity for primary human
ﬁbroblasts (HFFs; CC50) was undetectable at concentrations
up to 100 mM, indicating that the new quinazolines and
hybrid compounds are selective. Importantly, the ﬂuorescent
quinazolines could nicely be depicted both in extracellular
and intracellular localizations when analysing primary
HFFs and virus-infected cells using confocal laser-scanning
microscopy. An accumulation of ﬂuorescent quinazolines was
mostly observed in cytoplasmic areas, thus visually indicating
their efﬁcient cellular uptake. These results open up
new perspectives for molecular imaging in the drug
development process and mechanistic studies, avoiding the
requirement of linkage of external ﬂuorescent labels to potential
drug molecules.
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Figure 1 | Quinazoline scaffolds with different substitution patterns. (a) List of the selected corresponding non-ﬂuorescent quinazoline-marketed drugs:
Alfuzosin (adrenergic blocker), Bunazosin (antihypertensive agent), Prazosin (adrenergic blocker), Terazosin (adrenergic blocker), Erlotinib (anticancer
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ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15071
2 NATURE COMMUNICATIONS | 8:15071 | DOI: 10.1038/ncomms15071 | www.nature.com/naturecommunications
Results
Proposed one-pot approach towards ﬂuorescent quinazolines.
Inspired by the power of the domino concept introduced by
Tietze16,22, we envisioned the possibility of designing a
multicomponent one-pot process, involving domino reactions,
which might allow to generate quinazolines starting from simple
precursors: aldehydes, nitroalkenes and malononitrile (Fig. 2).
The proposed unprecedented quinazolines, bearing amino
(donor) and cyano (acceptor) groups at the same time, were
expected to demonstrate desirable ﬂuorescence properties.
One-pot synthesis of cyclohexenes and 2,6-dicyanoanilines. We
started by exploring a reaction of trans-b-nitrostyrene (1), ben-
zaldehyde (2) and malononitrile (3; Figs 3 and 4a). Our most
recent ﬁnding of an imidazole-catalysed six-step linear domino
reaction of malononitrile with phenylethanal derivatives24
inspired us to apply imidazole as a catalyst also for this new
transformation (Supplementary Fig. 1). To our delight, the
domino process using dichloromethane as a solvent in presence
of imidazole at room temperature resulted in highly
functionalized cyclohexene derivative 4a. Structure and relative
stereochemistry of isolated major diastereomer 4a was conﬁrmed
by X-ray analysis (Fig. 3).
We next screened further commercially available bases
(Supplementary Fig. 1). A signiﬁcant improvement of product
yields to 499% was observed in presence of hydroquinine
1,4-phthalazinediyl diether ((DHQ)2PHAL, Fig. 4a), well known
as a ligand in osmium-catalysed Sharpless dihydroxylation
reaction25.
The proposed mechanism of the branched domino reaction
was conﬁrmed by ESI- and APPI-MS studies (Fig. 3). In presence
of a catalyst, we observed signals at m/z 154 [M]þ and m/z 218
[Mþ 3H]3þ , which correspond to products of two transforma-
tions running in parallel, Knoevenagel (step 1) and nitro-Michael
(step 2) reactions, respectively. A signal at m/z 370 [MþH]þ
corresponds to product of a subsequent nitroalkane-Michael
reaction (step 3) between previously formed nitroalkane deriva-
tive (donor) and a Knoevenagel product (Michael acceptor). The
last steps, leading to target compound 4a, involve intramolecular
addition (step 4) and tautomerization (step 5).
Next, optimal conditions for 2,6-dicyanoaniline derivative 5a
formation (key intermediate for quinazoline synthesis according
to Fig. 2) from cyclohexene 4a were studied (see Supplementary
Table 1). Notably, 2,6-dicyanoaniline derivatives have recently
attracted considerable attention, since they exhibit strong
ﬂuorescence in ultraviolet light and may have utility in synthesis
of ﬂuorescent materials, non-natural photosynthetic systems,
materials with semiconducting or nonlinear optical properties,
molecular electronic devices and light-emitting diodes26–29.
Since direct aromatization of 4a was not successful using
different oxidizing agents (see Supplementary Table 1), we
assumed that hydrolysis of CN groups to COOH might facilitate
the subsequent aromatization step through CO2 release and
might also prevent generation of toxic hydrogen cyanide (HCN).
Applying acetic acid (AcOH) and carrying out the reaction at
130 C for 6.5 h, product 4a0 with a quaternary carbon centre was
isolated in 75% yield (Fig. 4b). Subsequently, we reacted 4a0 with
Ac2O/Py, giving desired product 5a in 95% yield. Next, we turned
our attention to ﬁnding the optimal conditions for two-step
one-pot synthesis of 5a from 4a (Fig. 4c). Carrying out the
reaction in presence of AcOH/Py (1:1) at 80 C for 15 h, desired
product 5a was isolated in 41% yield. We obtained, furthermore,
performing the same reaction under otherwise identical
conditions—but in presence of ammonium acetate (6) as an
additive—the product 5a in a higher yield of 52% over two steps
(Fig. 4c).
Another speciﬁc aim was to combine the ﬁve-step branched
domino reaction with the optimized two-step linear domino
reaction in a seven-step one-pot process, which we successfully
realized (Fig. 5a). Noteworthy, all reactions investigated can be
effected in 31–67% overall yield over seven steps. Generally,
higher yields (61–67% for 5a–5e) were obtained using substrates
with both neutral and electron-withdrawing moieties on benzene
rings.
Laser-induced ﬂuorescence imaging with 2,6-dicyanoaniline.
Using the combinatorial laser-induced forward transfer
method30, we patterned selected new ﬂuorophore 5d in the form
of an array consisting of 10 10 spots (Fig. 5b), and the logo of
Friedrich-Alexander University, consisting of single overlapping
spots (Fig. 5c). Hereby, laser irradiation (wavelength of 532 nm)
transferred the small amounts of 2,6-dicyanoaniline derivative
5d from the donor slide to an acceptor (see Supplementary Fig. 2
and Supplementary Note 1). In accord with the absorption
spectrum of compound 5d, an excitation wavelength of 254 nm
was chosen. The expected ﬂuorescent image was detected with an
optical set-up developed for rapid wide-ﬁeld screening of
chromophores (see Supplementary Fig. 2). The fact that the
combinatorial laser-induced forward transfer procedure does not
harm push–pull chromophore 5d opens up the possibility to test
and optimize optical properties in a high-density array format by
performing parallel screenings for different chromophores at the
same time. In addition, 5d showed also solvatochromic properties
(Fig. 5d).
One-pot 10-step synthesis of ﬂuorescent quinazolines. Conse-
quently, anticipated one-pot synthesis of quinazolines 7a–i was
performed via combination of our new seven-step one-pot pro-
cess with a three-step linear domino reaction using formamide as
a suitable reagent in 2 h reaction time (Figs 3 and 6). Reaction of
5a with formamide can proceed through an imine formation
(step 1), intramolecular condensation (step 2) and tautomeriza-
tion (step 3) linear domino process (Fig. 3). We explored the
substrate scope of the resulting 10-step one-pot process (Fig. 6).
All applied aromatic substrates (carrying either neutral, electron-
withdrawing or electron-donating groups) afforded high overall
yields of 20–50% over 10 steps. Remarkably, calculated average
yields of every individual step in these multistep one-pot reac-
tions, deduced from a total yield of up to 67% (seven-step, Fig. 5a)
and up to 50% (10-step, Fig. 6) is 94% and 93%, respectively.
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Figure 2 | Proposed convenient synthesis of ﬂuorescent quinazolines. One-pot multistep synthetic approach towards 4,5,7,8-substituted quinazolines
from simple compounds.
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Photophysical study of selected ﬂuorescent quinazoline. On
example of selected compound 7h we demonstrate the solva-
tochromy of new quinazolines (Fig. 6). Inspired by this inter-
esting property, we conducted a basic photophysical study of
7h in acetonitrile (see Supplementary Fig. 3, Supplementary
Discussion and Supplementary Methods). First insights into the
excited-state properties came from steady-state ﬂuorescence
measurements. Quinazoline compound 7h exhibits strong ﬂuor-
escence between 370 and 600 nm, with a maximum at 439 nm.
The ﬂuorescence properties of potentially bioactive compounds,
for example, antiviral, antimalarial and anticancer agents, might
be very useful for an in vitro monitoring of compound-treated
cultured cells by use of ﬂuorescence microscopy.
Synthesis of artesunic acid–quinazoline hybrids. Human cyto-
megalovirus (HCMV) is a major human pathogen showing
worldwide prevalence. Prevention and clinical interventions for
HCMV disease are limited, since cross-resistance to all approved
anti-HCMV drugs is increasingly observed31. As alternatives to
standard drugs23,32, our ongoing search for highly active hybrid
molecules33–35, which exceed their parent compounds in activity
against HCMV, resulted in synthesis of new artesunic
acid–quinazoline hybrids 8 and 9 (Fig. 7a and Supplementary
Methods). We chose compounds 7g and 7h (Fig. 6) as coupling
partners, since their ﬂuorescence properties were considered
beneﬁcial for biological investigations. Artesunic acid on the
other hand was selected because it proved to be a valuable
building block in order to get highly bioactive compounds with
just a few chemical transformations and also because of its
promising pharmacological properties23,32,35.
Antiviral activities of quinazolines and hybrid compounds.
Subsequently, the selected quinazolines 7b, 7g, 7h, 7i and hybrids
8, 9 were quantitatively analysed for their antiviral activity against
HCMV (Table 1). The new quinazolines 7b, 7g, 7h and 7i con-
sistently demonstrated a high activity against HCMV, among
which the quinazoline heterocycle 7i displayed the most potent
antiviral efﬁcacy with a lower in vitro EC50 value than the
reference drug ganciclovir (Table 1).
Furthermore, our results clearly demonstrate the great
potential of the hybridization concept. Artesunic acid–
quinazoline hybrids 8 and 9 (EC50 0.6±0.1 and 0.1±0.0 mM,
respectively) are not only 6- to 46-fold more active than their
parent compounds: artesunic acid, 7g and 7h (EC50 3.8±0.4,
4.9±0.2 and 4.6±0.9 mM, respectively); they also exceed antiviral
activity of the reference drug ganciclovir (EC50 2.6±0.5 mM) that
is in use for standard treatment of HCMV infections. The
measurement of antiviral activity was based on automated
ﬂuorometry using a green ﬂuorescent protein (GFP)-expressing,
recombinant HCMV (excitation 485 nm, emission 535 nm;
see Supplementary Note 2, Supplementary Data 1 and
Supplementary Fig. 4 for dose–response curves).
In addition, EC50 values were conﬁrmed using non-GFP-
expressing HCMV (strain AD169) by a classical plaque formation
assay on HFFs (n¼ 4), providing data consistent with the
GFP-based data shown in Table 1, that is, compound 7h,
7.3±0.7 mM; compound 8, 0.3±0.0 mM; compound 9,
0.3±0.1 mM. Moreover, antiviral activity was clearly separated
from putative cytotoxic effects because of the results obtained
with a standard trypan blue exclusion assay. For all compounds,
cytotoxicity for primary HFFs (CC50) was low or undetectable at
concentrations up to 100 mM (that is, cytotoxicity values obtained
at the highest test concentration of 100 mM remained under the
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cutoff level for all compounds except artesunic acid also
comprising a high CC50 of 82.0±0.9), while anti-HCMV
activities (EC50) were in a sub- or single-digit micromolar range.
Consistent with these ﬁndings are results from a MTS-based cell
proliferation assay, showing moderate or no antiproliferative
effects on HFFs for all analysed compounds in concentrations up
to 30 mM (see Supplementary Fig. 5 and Supplementary
Methods). Thus, the new quinazolines and hybrid compounds
can be regarded as selective, which is one of the most important
aspects in drug design.
Discussion
We describe the operationally simple and expeditious one-pot
synthetic method—merging multistep domino reactions under
fully metal-free conditions—providing unprecedented convenient
access to a new class of antiviral 4,5,7,8-substituted quinazolines,
bearing amino and cyano groups at the same time, in high overall
yields, starting from simple and readily available compounds
(Figs 3 and 6). Only one puriﬁcation step is involved, leading to
signiﬁcant reduction of costs, waste and labour input. The
investigated quinazolines 7b, 7g, 7h, 7i exhibit signiﬁcant activity
against HCMV. Furthermore, selected ﬂuorescent quinazolines
7g, 7h were applied for synthesis of ﬁrst artesunic acid–
quinazoline hybrids 8 and 9, which are, strikingly, also
ﬂuorescent and display superior anti-HCMV activity (EC50 down
to 0.1±0.0 mM) compared to the parent compounds (artesunic
acid and quinazolines) as well as the reference drug ganciclovir
(EC50 2.6±0.5 mM).
When analysing primary HFFs, the ﬂuorescent compounds 7g,
7h and 9 could nicely be depicted both in extracellular
(transparent arrows) and intracellular localizations (ﬁlled arrows;
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Fig. 7b,c). Interestingly, the extracellular signals included well-
ordered crystalline structures (Fig. 7b, panel 8; Fig. 7c, panels
8–9) in the range of the applied concentrations (1–10 mM). The
intracellular ﬂuorescence pattern of the compounds showed a
speckled accumulation mostly in cytoplasmic areas, thus visually
indicating their efﬁcient cellular uptake (Fig. 7b, panels 2–5 and
7–10; Fig. 7c, panels 3–5 and 8–10). A nonﬂuorescent
artemisinin-derived control compound (Fig. 7c, panels 2 and 7;
see also Supplementary Fig. 6), the DMSO panels (solvent
controls) as well as the inspection of different excitation
wavelengths of the confocal laser-scanning microscopy conﬁrmed
the speciﬁcity of signals and a lack of unwarranted cross-
ﬂuorescence. Of note, the ﬂuorescent capacity of compounds 7h,
7g and 9 (depicted by microscopic imaging scored at a laser
wavelength of 405 nm; Fig. 7b–d) did not interfere with GFP
ﬂuorometry, so that control measurements with these compounds
did not produce signals above background levels. Importantly, the
evaluation of virus-infected cells could also be included in this
analytic approach, opening new perspectives in the investigation
of antiviral activity and mechanistic details of the compounds
(the latter point might be supported by the study of intracellular
drug–target binding and localization in future applications). An
indirect immunoﬂuorescence counterstaining of viral and cellular
proteins36,37 led to the detection of nuclear markers, that is, the
viral protein kinase pUL97 and cellular lamins type A/C (Fig. 7d,
panels 4, 9, 14 or 5, 10, 15, respectively), in the context of
extracellular and intracellular ﬂuorescence signals of compounds
7h and 9 (Fig. 7d, panels 1–5 or 6–15, respectively). The direct co-
staining of putative target proteins of the compounds seems to be
a further realistic goal and might be realizable at a later stage.
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six-well plates on cover slips and were either directly incubated with compounds by addition to the culture media for 20 h (c) or were added after HCMV
infection (b,d; compound addition at 50 h post infection, ﬁxation and analysis of cells 20 h later; scale bar, 10mm). The chosen concentrations were 10 mM
for compounds 7h, 7g and 9, or 1mM for compound 9 in panels 4, 9 (b), panels 5, 10 (c) and panels 6–10 (d), referring to the compounds’ EC50 values of
anti-HCMV activity (see Table 1). The depicted images are representative for three independent experiments. Lack of mycoplasm contamination was
veriﬁed by routine 4,6-diamidino-2-phenylindole staining. General procedures of cell ﬁxation, indirect immunoﬂuorescence staining of proteins (d) and
microscopic analysis have been described elsewhere36,37.
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The fact that the studied antiviral quinazoline compounds are
ﬂuorescent opens up a new vista of molecular imaging in drug
development and mechanistic studies, avoiding the requirement
of linkage of external ﬂuorescent markers to quinazoline drugs.
Through ﬂuorescence these new compounds might then be
analysed for details of putative biological activities, such as
in vitro inhibitory properties against HCMV as demonstrated in
the present study and also for the aspects of drug delivery in
single cells and whole tissue.
In general, these unprecedented ﬁndings have important future
implications for the development of efﬁcient drugs (for example,
antiviral, anticancer and antimalarial) for clinics based on
ﬂuorescent bioactive heterocycles as lead compounds.
Methods
General methods. For details of the reaction optimization procedures and product
characterizations, see Supplementary Fig. 1, Supplementary Table 1 and
Supplementary Methods. For X-ray data of compounds 4a, 4a0 and 7a, see
Supplementary Tables 2–4. For ﬂuorescent imaging with 5d, see Supplementary
Fig. 2 and Supplementary Note 1. For photophysical studies of compound 7h, see
Supplementary Fig. 3, Supplementary Methods and Supplementary Discussion. For
antiviral studies of selected compounds in this manuscript, see Supplementary
Figs 4 and 5, Supplementary Methods and Supplementary Note 2. For 1H, 13C
NMR spectra of the compounds in this article, see Supplementary Figs 6–52.
Data availability. CCDC 1472467 (4a), 1472469 (4a0) and 1472470 (7a) contain
the supplementary crystallographic data for this paper. These data are provided
free of charge by The Cambridge Crystallographic Data Centre. The authors
declare that all other data supporting the ﬁndings of this study are available within
the article and its Supplementary Information ﬁle.
References
1. Alafeefy, A. M., Kadi, A. A., Al-Deeb, O. A., El-Tahir, K. E. & Al-Jaber, N. A.
Synthesis, analgesic and anti-inﬂammatory evaluation of some novel
quinazoline derivatives. Eur. J. Med. Chem. 45, 4947–4952 (2010).
2. Hutterer, C. et al. The chemical class of quinazoline compounds provides a core
structure for the design of anticytomegaloviral kinase inhibitors. Antiviral Res.
134, 130–143 (2016).
3. Madapa, S. et al. Search for new pharmacophores for antimalarial activity. Part
II: synthesis and antimalarial activity of new 6-ureido-4-anilinoquinazolines.
Bioorg. Med. Chem. 17, 222–234 (2009).
4. Zhang, Y. et al. Synthesis and anticancer activities of 5,6,7-trimethoxy-N-
phenyl(ethyl)-4-aminoquinazoline derivatives. Eur. J. Med. Chem. 66, 335–344
(2013).
5. Erba, E., Pocar, D. & Valle, M. n-Triazolines. Part 41.1 A new synthesis of
2-alkylquinazolines and 2,9-dialkylpyrimido[4,5-b] indoles. J.Chem. Soc. Perkin
Trans. 1, 421–426 (1999).
6. Bedi, P. M., Kumar, V. & Mahajan, M. P. Synthesis and biological activity of
novel antibacterial quinazolines. Bioorg. Med. Chem. Lett. 14, 5211–5213
(2004).
7. Zhang, Z.-H., Zhang, X.-N., Mo, L.-P., Li, Y.-X. & Ma, F.-P. Catalyst-free
synthesis of quinazoline derivatives using low melting sugar–urea–salt mixture
as a solvent. Green Chem. 14, 1502 (2012).
8. Karnakar, K., Kumar, A. V., Murthy, S. N., Ramesh, K. & Nageswar, Y. V. D.
Recyclable graphite oxide promoted efﬁcient synthesis of 2-phenyl quinazoline
derivatives in the presence of TBHP as an oxidant. Tetrahedron Lett. 53,
4613–4617 (2012).
9. Du, Z. & Shao, Z. Combining transition metal catalysis and organocatalysis—
an update. Chem. Soc. Rev. 42, 1337–1378 (2013).
10. Deiana, L. et al. Highly enantioselective cascade transformations by merging
heterogeneous transition metal catalysis with asymmetric aminocatalysis. Sci.
Rep. 2, 851 (2012).
11. Loh, C. C., Badorrek, J., Raabe, G. & Enders, D. Merging organocatalysis and
gold catalysis: enantioselective synthesis of tetracyclic indole derivatives
through a sequential double Friedel-Crafts type reaction. Chem. Eur. J. 17,
13409–13414 (2011).
12. Loh, C. C. & Enders, D. Merging organocatalysis and gold catalysis—a
critical evaluation of the underlying concepts. Chem. Eur. J. 18, 10212–10225
(2012).
13. Hack, D. et al. Combining silver catalysis and organocatalysis: a sequential
Michael addition/hydroalkoxylation one-pot approach to annulated coumarins.
Org. Lett. 16, 5188–5191 (2014).
14. Tejedor, D., Mendez-Abt, G., Cotos, L. & Garcia-Tellado, F. Merging domino
and redox chemistry: stereoselective access to di- and trisubstituted
b,g-unsaturated acids and esters. Chem. Eur. J. 18, 3468–3472 (2012).
15. Nicewicz, D. A. & MacMillan, D. W. Merging photoredox catalysis with
organocatalysis: the direct asymmetric alkylation of aldehydes. Science 322,
77–80 (2008).
16. Tietze, L. F. Domino reactions in organic synthesis. Chem. Rev. 96, 115–136
(1996).
17. Enders, D., Huttl, M. R., Grondal, C. & Raabe, G. Control of four stereocentres
in a triple cascade organocatalytic reaction. Nature 441, 861–863 (2006).
18. Enders, D., Grondal, C. & Huttl, M. R. Asymmetric organocatalytic domino
reactions. Angew. Chem. Int. Ed. 46, 1570–1581 (2007).
19. Grondal, C., Jeanty, M. & Enders, D. Organocatalytic cascade reactions as a new
tool in total synthesis. Nat. Chem. 2, 167–178 (2010).
20. Albrecht, L., Jiang, H. & Jorgensen, K. A. A simple recipe for sophisticated
cocktails: organocatalytic one-pot reactions—concept, nomenclature, and
future perspectives. Angew. Chem. Int. Ed. 50, 8492–8509 (2011).
21. Zeng, X., Ni, Q., Raabe, G. & Enders, D. A branched domino reaction:
asymmetric organocatalytic two-component four-step synthesis of
polyfunctionalized cyclohexene derivatives. Angew. Chem. Int. Ed. 52,
2977–2980 (2013).
22. Tietze, L. F. Domino Reactions: Concepts for Efﬁcient Organic Synthesis
(Wiley-VCH, 2014).
23. Reiter, C. et al. Highly potent artemisinin-derived dimers and trimers: synthesis
and evaluation of their antimalarial, antileukemia and antiviral activities.
Bioorg. Med. Chem. 23, 5452–5458 (2015).
24. Bock, C. M. et al. Generation of complex azabicycles and carbobicycles from
two simple compounds in a single operation through a metal-free six-step
domino reaction. Chem. Eur. J. 22, 5189–5197 (2016).
25. Dupau, P., Epple, R., Thomas, A. A., Fokin, V. V. & Sharpless, K. B. Osmium-
catalyzed dihydroxylation of oleﬁns in acidic media: old process, new tricks.
Adv. Synth. Catal. 344, 421–433 (2002).
26. Kanis, D. R., Ratner, M. A. & Marks, T. J. Design and construction of molecular
assemblies with large second-order optical nonlinearities. Quantum chemical
aspects. Chem. Rev. 94, 195–242 (1994).
27. Bendikov, M., Wudl, F. & Perepichka, D. F. Tetrathiafulvalenes, oligoacenenes,
and their buckminsterfullerene derivatives: the brick and mortar of organic
electronics. Chem. Rev. 104, 4891–4946 (2004).
Table 1 | EC50 values of anti-HCMV activity (AD169-GFP) determined in primary HFFs.
Compound HCMV EC50 (lM)*,w HFFs CC50 (lM)*,z
Ganciclovir 2.6±0.5 4100
Artesunic acid 3.8±0.4 82.0±0.9
Artemisinin 410 4100
7b 9.5±4.8 4100
7g 4.9±0.2 4100
7h 4.6±0.9 4100
7i 0.6±0.1 4100
8 0.6±0.1 4100
9 0.1±0.0 4100
*The cell culture-based systems for the determination of EC50 and CC50 values (trypan blue exclusion assay) has been previously reported
38.
wn¼4.
zn¼ 6 (except artesunic acid: n¼ 3).
GFP, green ﬂuorescent protein; HCMV, human cytomegalovirus; HFF, human ﬁbroblast.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15071
8 NATURE COMMUNICATIONS | 8:15071 | DOI: 10.1038/ncomms15071 | www.nature.com/naturecommunications
28. Kulkarni, A. P., Kong, X. & Jenekhe, S. A. High-performance organic light-
emitting diodes based on intramolecular charge-transfer emission from donor–
acceptor molecules: signiﬁcance of electron-donor strength and molecular
geometry. Adv. Funct. Mater. 16, 1057–1066 (2006).
29. Das, P., Butcher, R. J. & Mukhopadhyay, C. Zinc titanate nanopowder: an
advanced nanotechnology based recyclable heterogeneous catalyst for the one-
pot selective synthesis of self-aggregated low-molecular mass acceptor–donor–
acceptor–acceptor systems and acceptor–donor–acceptor triads. Green Chem.
14, 1376 (2012).
30. Loefﬂer, F. F. et al. High-ﬂexibility combinatorial peptide synthesis with laser-
based transfer of monomers in solid matrix material. Nat. Commun. 7, 11844
(2016).
31. Lurain, N. S. & Chou, S. Antiviral drug resistance of human cytomegalovirus.
Clin. Microbiol. Rev. 23, 689–712 (2010).
32. Reiter, C. et al. New efﬁcient artemisinin derived agents against human leukemia
cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-
trioxane-ferrocene hybrids. Eur. J. Med. Chem. 97, 164–172 (2015).
33. Tietze, L. F., Bell, H. P. & Chandrasekhar, S. Natural product hybrids as new
leads for drug discovery. Angew. Chem. Int. Ed. 42, 3996–4028 (2003).
34. Tsogoeva, S. B. Recent progress in the development of synthetic hybrids of
natural or unnatural bioactive compounds for medicinal chemistry. Mini-Rev.
Med. Chem. 10, 773–793 (2010).
35. Fro¨hlich, T., Capci Karago¨z, A., Reiter, C. & Tsogoeva, S. B. Artemisinin-
derived dimers: potent antimalarial and anticancer agents. J. Med. Chem. 59,
7360–7388 (2016).
36. Steingruber, M. et al. The interaction between cyclin B1 and cytomegalovirus
protein kinase pUL97 is determined by an qctive kinase domain. Viruses 7,
4582–4601 (2015).
37. Milbradt, J. et al. The prolyl isomerase Pin1 promotes the herpesvirus-induced
phosphorylation-dependent disassembly of the nuclear lamina required for
nucleocytoplasmic egress. PLoS Pathog. 12, e1005825 (2016).
38. Hutterer, C. et al. A novel CDK7 inhibitor of the Pyrazolotriazine class exerts
broad-spectrum antiviral activity at nanomolar concentrations. Antimicrob.
Agents Chemother. 59, 2062–2071 (2015).
Acknowledgements
We gratefully acknowledge the ﬁnancial support from Deutsche Forschungsgemeinschaft
(DFG) by grants TS 87/17-1 (SPP 1807, Priority Programme ‘Control of London Dis-
persion Interactions in Molecular Chemistry’), TS 87/15-1, TS 87/16-3 and MM 1289/7-1/
7-3. We also thank the Graduate School Molecular Science (GSMS), Interdisciplinary
Center for Molecular Materials (ICMM), the Wilhelm Sander-Stiftung (Grants Nr.
2014.019.1 and 2011.085.1-2), BMBF (Grant Nr. 031A095C) and Emerging Fields
Initiative (EFI) ‘Chemistry in Live Cells’ supported by Friedrich-Alexander-Universita¨t
Erlangen-Nu¨rnberg for research funding.
Author contributions
F.E.H. and A.A.G. conducted the domino reactions and one-pot multistep transforma-
tions. F.E.H. contributed to the development and evaluation of the scope of 2,6-dicyano-
anilines and quinazolines synthesis. A.A.G. contributed to the scope of 2,6-dicyano-
anilines synthesis. T.F. performed the synthesis of artesunic acid–quinazoline hybrid
molecules. F.H. conducted the X-ray analysis. A.K. performed the photophysical mea-
surements. H.B. and C.H. performed antiviral tests and cytotoxicity studies. M.S. per-
formed confocal microscopy analyses. M.M. and C.H. supervised the biological
investigations of new quinazoline molecules, evaluated data and included the relevant
sections into the manuscript. C.v.B.-K., D.S.M., T.F. conducted and A.N.-M. supervised
the laser-induced imaging with selected new ﬂuorophore. S.B.T. conceived and directed
the research, supervised the synthetic experiments and wrote the manuscript; all authors
discussed the results and commented on the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Held, F. E. et al. Facile access to potent antiviral quinazoline
heterocycles with ﬂuorescence properties via merging metal-free domino reactions.
Nat. Commun. 8, 15071 doi: 10.1038/ncomms15071 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15071 ARTICLE
NATURE COMMUNICATIONS | 8:15071 | DOI: 10.1038/ncomms15071 | www.nature.com/naturecommunications 9
